·Confidence 95%
Moderna Shares Surge 177% on Positive Melanoma Trial Results
Moderna's stock skyrocketed 177% following positive Phase 3 melanoma trial results in collaboration with Merck, prompting investor interest in FDA plans.
MRNA ↑ Very strong
#Merck
2 articles tagged with #Merck
·Confidence 80%
Treasury Increases Bond Buybacks Amid Market Developments
The U.S. Treasury has announced an increase in bond buybacks, a move that could influence market dynamics. Moderna and Merck also contribute to renewed